REGN

Regeneron Pharmaceuticals, Inc.

6 catalysts on file

REGN

Regeneron Pharmaceuticals, Inc.

Catalyst AI-extracted

cemdisiran

myasthenia gravis

52d ago ~ Jun 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

REGN

Regeneron Pharmaceuticals, Inc.

Catalyst AI-extracted

fianlimab

first-line metastatic melanoma

52d ago ~ Jun 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

REGN

Regeneron Pharmaceuticals, Inc.

Catalyst AI-extracted

garetosmab

fibrodysplasia ossificans progressiva (FOP)

T-minus 10 days ~ Aug 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

REGN

Regeneron Pharmaceuticals, Inc.

Approval Confirmed

Dupixent

chronic spontaneous urticaria (CSU)

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

REGN

Regeneron Pharmaceuticals, Inc.

Approval Confirmed

EYLEA HD

wet age-related macular degeneration (wAMD) and diabetic macular edema (DME)

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

REGN

Regeneron Pharmaceuticals, Inc.

Approval Confirmed

Otarmeni

genetic hearing loss

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →